Trevi Therapeutics Inc.

4.26
-0.26 (-5.75%)
At close: Mar 03, 2025, 3:59 PM
4.35
2.11%
After-hours: Mar 03, 2025, 07:29 PM EST

Trevi Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Cash & Equivalents 32.4M 12.59M 36.83M 45M 57.31M 17.16M 22.02M 8.29M
Short-Term Investments 50.57M 107.92M n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 297K 205K 334K 532K 19K 1.55M 52K 12K
Receivables n/a n/a n/a 265K 558K 184K n/a n/a
Inventory n/a n/a n/a 895K 1.6M 1.4M 63K n/a
Other Current Assets 4.58M 2.11M 886K 1M 1.68M 1.44M 142K 106K
Total Current Assets 87.55M 122.62M 37.96M 46.27M 59.55M 18.79M 22.16M 8.39M
Property-Plant & Equipment 1.56M 194K 184K 330K 430K 149K 14K 5K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 1.86M 399K 518K 862K 449K 1.7M 66K 17K
Total Assets 89.4M 123.02M 38.48M 47.13M 60M 20.49M 22.23M 8.41M
Account Payables 1.81M 2.86M 2.85M 2.02M 1.6M 603K 537K 445K
Deferred Revenue n/a n/a 3.81M n/a n/a n/a n/a n/a
Short-Term Debt 306K 7.03M 5.95M 226K 198K n/a 5.29M 16.99M
Other Current Liabilities 3.71M 3.52M 3.92M 3.31M 3.4M 2.07M 1.3M 2.95M
Total Current Liabilities 5.82M 13.4M 12.72M 5.55M 5.2M 2.68M 7.13M 20.39M
Long-Term Debt 1.03M 2.15M 8.68M 14.1M 257K 1.14M n/a 5.12M
Other Long-Term Liabilities n/a 3K n/a 196K n/a 460K 325K 310K
Total Long-Term Liabilities 1.03M 2.16M 8.68M 14.29M 257K 506K 325K 5.43M
Total Liabilities 6.86M 15.56M 21.4M 19.85M 5.46M 3.18M 7.45M 25.82M
Total Debt 1.34M 9.18M 14.63M 14.21M 356K 1.1M 5.29M 22.11M
Common Stock 68K 60K 29K 19K 18K 101K 4K 4K
Retained Earnings -239.13M -210.07M -180.92M -146.98M -114.22M -109.5M -84.43M -72.16M
Comprehensive Income -29K -122K n/a n/a -60M -46K -23K -0.00
Shareholders Equity 82.55M 107.46M 17.07M 27.28M 54.55M 17.31M 14.78M -17.41M
Total Investments 50.57M 107.92M n/a n/a n/a n/a n/a n/a